首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1404806

獸醫腫瘤市場市場規模、佔有率、趨勢分析報告：按治療、按動物類型、按癌症類型、按地區、細分市場預測，2024-2030 年

Veterinary Oncology Market Size, Share & Trends Analysis Report By Therapy (Radiotherapy, Surgery), By Animal Type (Canine, Feline), By Cancer Type, By Region, And Segment Forecasts, 2024 - 2030

出版日期: 2023年11月29日 | 出版商:

Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

獸醫腫瘤學市場成長與趨勢：

Grand View Research, Inc.的最新報告顯示，到2030年，全球獸醫腫瘤市場規模預計將達到5.779億美元。

預計2024年至2030年複合年成長率為11.29%。寵物癌症盛行率的增加和對獸醫診斷的需求預計將在預測期內推動市場發展。

全球採用犬癌症登記處來估計癌症發生率也是市場成長的促進因素。根據2019年2月《獸醫科學前沿》報道，瑞士犬癌症登記處（SCCR）被用作資料來源並進行彙編，以供未來犬類和人類癌症的比較研究。該資料庫進一步有助於減少人群中惡性的發生，從而促進市場成長。

進行獸醫腫瘤學研究的研究人員正在進一步推動獸醫腫瘤學市場的成長。例如，2017 年 8 月，伊利諾大學進行了一項研究，旨在更準確地檢測狗的頭頸部腫瘤轉移（癌症在體內的擴散）。此外，市場參與者也關注新產品創新和策略聯盟。例如，Oasmia Pharmaceutical AB 的子公司 AdvaVet 於 2018 年開發了基於奈米顆粒配方的 XR17 技術，該技術使單一活性藥物成分 (API) 或多種 API 水溶性。它是聯合治療，也是寵物動物許多癌症疾病的標準治療方法。

獸醫腫瘤學市場報告亮點

伴同性動物中癌症盛行率的不斷上升、評估寵物癌症治療的安全性和有效性的多項臨床試驗研究以及獸醫癌症治療的技術進步正在推動市場的成長，預計將創造機會。
化療，無論是單獨治療還是與其他治療方法相結合，在未來幾年中將佔據最大的收益佔有率，因為它擴大用於寵物癌症治療。
2023 年，狗的收益佔比最大，狗的數量不斷成長，而且與貓相比，狗的癌症患病率更高。
由於其在伴同性動物中的高死亡率，淋巴瘤在 2023 年的其他癌症類型中佔據了市場主導地位。根據 2018 年獸醫和比較腫瘤學，胃腸道 (GI) 淋巴瘤是犬科動物中最常見的腫瘤。
由於有利的政府政策、公司推出的新產品以及對獸醫腫瘤治療的巨額投資，截至 2023 年，北美佔據主導市場佔有率。
亞太地區正在經歷動物健康和支出的增加、患舉措的寵物數量不斷增加、政府對動物安全的關注以及遏制寵物癌症病例的多項舉措，預計將顯示出良好的成長。
主要企業包括勃林格殷格翰 (Boehringer Ingelheim)、PetCure Oncology、Elanco、Accuray Incorporated、瓦里安醫療系統 (Varian Medical Systems)、碩騰 (Zoetis)、Karyopharm Therapeutics, Inc.、One Health 和 Regeneus Ltd。

市場體系展望
- 母市場展望
- 附隨市場前景
2023 年技術普及與成長前景圖
從使用者觀點分析
- 市場影響力分析
- 主要最終用戶名單
法律規範
- 監管狀況
- 標準和合規性
技術時間軸分析
獸醫腫瘤學市場動態
- 市場促進因素分析
- 市場抑制因素分析
產業分析-波特五力分析
- 供應商議價能力：中等
- 買方議價能力：低至中等
- 替代品的威脅：中等
- 新進入者的威脅：高
- 競爭公司之間的敵意：高
美國獸醫腫瘤學 - 按因素進行 SWOT 分析（政治和法律、經濟、社會和技術）
- 政治和法律形勢
- 經濟形勢
- 社會形勢
- 技術形勢
新型冠狀病毒影響分析

第4章獸醫腫瘤學市場：治療估計與趨勢分析

2023 年和 2030 年治療市場佔有率分析
治療儀表板
外科手術
放射線治療
化療
免疫療法
其他

第5章獸醫腫瘤學市場：動物類型估計與趨勢分析

2023 年和 2030 年動物類型市場佔有率分析
動物型儀表板
犬類
貓科動物
馬

第6章獸醫腫瘤學市場：癌症類型估計與趨勢分析

2020 年和 2028 年癌症類型市場佔有率分析
癌症類型儀表板
淋巴瘤
皮膚癌
肉瘤
其他

第7章獸醫腫瘤學市場：按產品、動物類型和最終用途的區域估計和趨勢分析

2023 年和 2030 年按地區分類的獸醫腫瘤市場佔有率
北美洲
- 北美獸醫腫瘤學市場估計與預測，2018-2030
- 美國
- 加拿大
歐洲
- 2018-2030 年歐洲獸醫腫瘤市場估計與預測
- 德國
- 英國
- 法國
- 義大利
- 西班牙
亞太地區
- 2018-2030 年亞太地區獸醫腫瘤市場估計與預測
- 中國
- 日本
- 印度
拉丁美洲
- 拉丁美洲獸醫腫瘤學市場估計與預測，2018-2030 年
- 巴西
- 墨西哥
中東和非洲
- MEA 獸醫腫瘤學市場估計和預測，2018-2030 年
- 南非

第8章獸醫腫瘤學市場：競爭形勢

市場參與分類
Major Deals &Strategic Alliances Analysis
公司市場分析
Boehringer Ingelheim International GmbH
- 公司簡介
- 財務績效
- 產品基準評效
- 策略舉措
Elanco
- 公司簡介
- 財務績效
- 產品基準評效
- 策略舉措
Zoetis
- 公司簡介
- 財務績效
- 產品基準評效
- 策略舉措
PetCure Oncology
- 公司簡介
- 財務績效
- 產品基準評效
- 策略舉措
Accuray Incorporated
- 公司簡介
- 財務績效
- 產品基準評效
- 策略舉措
Varian Medical Systems, Inc.
- 公司簡介
- 財務績效
- 產品基準評效
- 策略舉措
Nippon Zenyaku Kogyo Co. Ltd.（ZENOAQ）
- 公司簡介
- 產品基準評效
- 策略舉措
Morphogenesis
- 公司簡介
- 產品基準評效
- 策略舉措
Karyopharm
- 公司簡介
- 財務績效
- 產品基準評效
- 策略舉措
Regeneus Ltd.
- 公司簡介
- 財務績效
- 產品基準評效
- 策略舉措
OHC（One Health Company）
- 公司簡介
- 產品基準評效
- 策略舉措

簡介目錄圖表

Product Code: GVR-4-68038-182-5

Veterinary Oncology Market Growth & Trends:

The global veterinary oncology market size is expected to reach USD 577.9 million by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 11.29% from 2024 to 2030. Increasing prevalence of cancer in pets and demand for veterinary diagnostics are projected to drive the market over the forecast period.

Adoption of canine cancer registry globally to estimate cancer incidences is another driving factor for the market growth. According to frontiers in Veterinary Science in February 2019, the Swiss Canine Cancer Registry (SCCR) was used as a data source and was compiled for future comparative studies of canine and human cancers. This database is further helpful in mitigating the incidence of malignant tumors in the human population, thereby driving the market growth.

Researchers carrying out studies focused on veterinary oncology are further boosting the veterinary oncology market growth. For instance, University of Illinois in August 2017, carried out study that involves more precise detection of metastasis (spread of cancer through the body) for head and neck tumors in dogs. Moreover, the market players are also focusing on new product innovation and strategic collaborations. For instance, in 2018 AdvaVet, a subsidiary of Oasmia Pharmaceutical AB, developed XR17 technology, which is nanoparticle formulation based that makes a single Active Pharmaceutical Ingredient (API) or multiple APIs water soluble. It is a combination therapy and is also a standard treatment for a number of cancer diseases in pet animals.

Veterinary Oncology Market Report Highlights:

Increasing prevalence of cancer in companion animals, several clinical trial studies to evaluate the safety and effectiveness of cancer therapeutics for pets and technological advancements in veterinary oncology treatment are anticipated to create growth opportunities in the market.
Chemotherapy accounted for the largest revenue share over the coming years, owing to its increasing adoption for pet cancer treatment either alone or in combination with other therapies.
Canine segment held the largest revenue in 2023, increasing population of dogs and high prevalence of cancer in dogs as compared to cats.
Lymphoma dominated the market among other cancer types in 2023, due to the disease's high mortality rate in companion animals. According to the Veterinary and Comparative Oncology in 2018, Gastrointestinal (GI) Lymphoma is the most common neoplasm that contracts dog population.
North America held the dominant share of as of 2023, due to the favorable government policies, new product launch by the companies, and huge investment for veterinary oncology treatment.
Asia Pacific is anticipated to witness lucrative growth due to increasing focus on animal health and expenditure, increasing number of pet population being exposed to cancer, government focus on animal safety, and several initiatives to curb cancer cases in pet animals.
Some of the key companies are Boehringer Ingelheim, PetCure Oncology, Elanco, Accuray Incorporated, Varian Medical Systems, Zoetis, Karyopharm Therapeutics, Inc. One Health and Regeneus Ltd.

Chapter 1 Research Methodology & Scope

1.1 Market Segmentation & Scope
- 1.1.1 Segment Scope
- 1.1.2 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
- 1.3.1 Purchased database
- 1.3.2 GVR's Internal Database
- 1.3.3 Secondary sources
- 1.3.4 Primary Research
- 1.3.5 Details of Primary Research
1.4 Information or Data Analysis
- 1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
- 1.6.1 Target Population & Patient Stratification (Top-down estimation): mODEL 1
- 1.6.2 Assumptions/Key Considerations
- 1.6.3 Commodity Flow Analysis (Model 2)
1.7 List of Secondary Sources
1.8 Abbreviations
1.9 Report Objectives

Chapter 2 Executive Summary

2.1 Market Outlook, 2023
2.2 Segment Outlook
2.3 Competitive Outlook

Chapter 3 Veterinary Oncology Market Variables Trends & Scope

3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping by Technology, 2023
3.3 User Perspective Analysis
- 3.3.1 Market Influencer Analysis
- 3.3.2 List of Key End Users
3.4 Regulatory Framework
- 3.4.1 Regulatory Landscape
- 3.4.2 Standards & compliances
3.5 Technology Timeline Analysis
3.6 Veterinary Oncology Market Dynamics
- 3.6.1 Market Driver Analysis
  - 3.6.1.1 Increasing prevalence and incidence of cancer in pets
  - 3.6.1.2 Growing Research and investments in pet cancer therapy
  - 3.6.1.3 Rising focus on animal safety
  - 3.6.1.4 Increasing adoption of pet insurance
  - 3.6.1.5 Technological advancements in pet cancer treatment
- 3.6.2 Market Restraint Analysis
  - 3.6.2.1 High cost of pet cancer treatments
  - 3.6.2.2 Lack of awareness among pet owners about pet diseases
  - 3.6.2.3 Adverse effects of drugs used for pet cancer treatment
3.7 Industry Analysis - Porter's
- 3.7.1 Bargaining Power of Suppliers: Moderate
- 3.7.2 Bargaining Power of Buyers: Low to Moderate
- 3.7.3 Threat of Substitutes: Moderate
- 3.7.4 Threat of New Entrants: High
- 3.7.5 Competitive Rivalry: High
3.8 U.S. Veterinary Oncology - SWOT Analysis, by Factor (Political & Legal, Economic, Social and Technological)
- 3.8.1 Political and Legal Landscape
- 3.8.2 Economic Landscape
- 3.8.3 Social Landscape
- 3.8.4 Technology Landscape
3.9 Covid Impact Analysis

Chapter 4 Veterinary Oncology Market: Therapy Estimates & Trend Analysis

4.1 Therapy Market Share Analysis, 2023 & 2030
4.2 Therapy Dashboard
4.3 Surgery
- 4.3.1 Surgery market estimates and forecasts, 2018 - 2030 (USD Million)
4.4 Radiotherapy
- 4.4.1 Radiotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
4.5 Chemotherapy
- 4.5.1 Chemotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
4.6 Immunotherapy
- 4.6.1 Immunotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
4.7 Others
- 4.7.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5 Veterinary Oncology Market: Animal Type Estimates & Trend Analysis

5.1 Animal Type Market Share Analysis, 2023 & 2030
5.2 Animal Type Dashboard
5.3 Canine
- 5.3.1 Canine market estimates and forecasts, 2018 - 2030 (USD million)
5.4 Feline
- 5.4.1 Feline market estimates and forecasts, 2018 - 2030 (USD million)
5.5 Equine
- 5.5.1 Equine market estimates and forecasts, 2018 - 2030 (USD million)

Chapter 6 Veterinary Oncology Market: Cancer Type Estimates & Trend Analysis

6.1 Cancer Type Market Share Analysis, 2020 & 2028
6.2 Cancer Type Dashboard
6.3 Lymphoma
- 6.3.1 Lymphoma market estimates and forecasts, 2018 - 2030 (USD Million)
6.4 Skin Cancers
- 6.4.1 Skin Cancers market estimates and forecasts, 2018 - 2030 (USD Million)
6.5 Sarcomas
- 6.5.1 Sarcomas market estimates and forecasts, 2018 - 2030 (USD Million)
6.6 Others
- 6.6.1 Other market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7 Veterinary Oncology Market: Regional Estimates & Trend Analysis by Product, Animal Type, and End-Use

7.1 Veterinary Oncology Market Shares By Region, 2023 & 2030
7.2 North America
- 7.2.1 North America Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.2.2 U.S.
  - 7.2.2.1 U.S. Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.2.3 Canada
  - 7.2.3.1 Canada Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
7.3 Europe
- 7.3.1 Europe Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.2 Germany
  - 7.3.2.1 Germany Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.3 UK
  - 7.3.3.1 UK Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.4 France
  - 7.3.4.1 France Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.5 Italy
  - 7.3.5.1 Italy Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.6 Spain
  - 7.3.6.1 Spain Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
7.4 Asia Pacific
- 7.4.1 Asia Pacific Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.2 China
  - 7.4.2.1 China Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.3 Japan
  - 7.4.3.1 Japan Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.4 India
  - 7.4.4.1 India Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
7.5 Latin America
- 7.5.1 Latin America Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.2 Brazil
  - 7.5.2.1 Brazil Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.3 Mexico
  - 7.5.3.1 Mexico Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
7.6 Middle East & Africa
- 7.6.1 MEA Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.2 South Africa
  - 7.6.2.1 SOuth Africa Veterinary Oncology market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8 Veterinary Oncology Market: Competitive Landscape

8.1 Market Participation Categorization
8.2 Major Deals & Strategic Alliances Analysis
8.3 Company market position analysis
8.4 Boehringer Ingelheim International GmbH
- 8.4.1 Company overview
- 8.4.2 Financial performance
- 8.4.3 Product benchmarking
- 8.4.4 Strategic initiatives
8.5 Elanco
- 8.5.1 Company overview
- 8.5.2 Financial performance
- 8.5.3 Product benchmarking
- 8.5.4 Strategic initiatives
8.6 Zoetis
- 8.6.1 Company overview
- 8.6.2 Financial performance
- 8.6.3 Product benchmarking
- 8.6.4 Strategic initiatives
8.7 PetCure Oncology
- 8.7.1 Company overview
- 8.7.2 Financial performance
- 8.7.3 Product benchmarking
- 8.7.4 Strategic initiatives
8.8 Accuray Incorporated
- 8.8.1 Company overview
- 8.8.2 Financial performance
- 8.8.3 Product benchmarking
- 8.8.4 Strategic initiatives
8.9 Varian Medical Systems, Inc.
- 8.9.1 Company overview
- 8.9.2 Financial performance
- 8.9.3 Product benchmarking
- 8.9.4 Strategic initiatives
8.10 Nippon Zenyaku Kogyo Co. Ltd. (ZENOAQ)
- 8.10.1 Company overview
- 8.10.2 Product benchmarking
- 8.10.3 Strategic initiatives
8.11 Morphogenesis
- 8.11.1 Company overview
- 8.11.2 Product benchmarking
- 8.11.3 Strategic initiatives
8.12 Karyopharm
- 8.12.1 Company overview
- 8.12.2 Financial performance
- 8.12.3 Product benchmarking
- 8.12.4 Strategic initiatives
8.13 Regeneus Ltd.
- 8.13.1 Company overview
- 8.13.2 Financial performance
- 8.13.3 Product benchmarking
- 8.13.4 Strategic Initiatives
8.14 OHC (One Health Company)
- 8.14.1 Company overview
- 8.14.2 Product benchmarking
- 8.14.3 Strategic Initiatives

簡介目錄圖表

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 List of veterinary oncology service providers
Table 4 North America veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 5 North America veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 6 North America veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 7 U.S. veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 8 U.S. veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 9 U.S. veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 10 Canada veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 11 Canada veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 12 Canada veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 13 Europe veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 14 Europe veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 15 Europe veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 16 UK veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 17 UK veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 18 UK veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 19 Germany veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 20 Germany veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 21 Germany veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 22 France veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 23 France veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 24 France veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 25 Italy veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 26 Italy veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 27 Italy veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 28 Spain veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 29 Spain veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 30 Spain veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 31 Asia Pacific veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 32 Asia Pacific veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 33 Asia Pacific veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 34 China veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 35 China veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 36 China veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 37 Japan veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 38 Japan veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 39 Japan veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 40 India veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 41 India veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 42 India veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 43 Latin America veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 44 Latin America veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 45 Latin America veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 46 Brazil veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 47 Brazil veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 48 Brazil veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 49 Mexico veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 50 Mexico veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 51 Mexico veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 52 MEA veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 53 MEA veterinary oncology market, by animal type, 2018 - 2030 (USD Million)
Table 54 MEA veterinary oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 55 South Africa veterinary oncology market, by Therapy, 2018 - 2030 (USD Million)
Table 56 South Africa oncology market, by animal type, 2018 - 2030 (USD Million)
Table 57 South Africa oncology market, by cancer type, 2018 - 2030 (USD Million)